Good news for all the people, who are suffering from warts! Finally, there’s a quick and effective solution for Warts!
What is Swift?
Swift was developed for the treatment of warts. It has since become a phenomenon due to it’s ease of use and success in ridding patients of unwanted warts.
Swift uses microwave energy, which is delivered through a special probe applied to the skin to treat the affected tissue. Multiple verrucas/warts can be treated at a single session. The treatment is quick, efficient with minimal pain. No anaesthetic or dressings are needed.
Does it hurt?
Like many treatments for skin lesions, some minor discomfort may be experienced.
Pain levels vary from person to person but most people undergoing swift microwave therapy liken it to to a sudden heat, lasting 2 – 3 seconds then quickly subsiding.
What can I do after treatment?
In some cases the treated area may feel sore, but it will not prevent you undertaking normal daily activities. No dressings are needed and you can get your foot wet.
How many treatments are need for warts?
This is dependent on how you respond to treatment. In some cases, you may need more than one treatment. Your podiatrist will be able to discuss this with you.
In recent research, 83% of the most stubborn warts cleared using Swift Microwave Therapy. The very best results were obtained with 3 treatments at 4 weekly intervals.
Can anyone receive this warts treatment?
With a few exceptions, most people with skin lesions would be able to have this treatment. It is suitable for children and diabetics who have good circulation. Your podiatrist will carry out an assessment prior to treatment and be able to advise you on this.
Source link
more recommended stories
Rheumatoid Arthritis Linked to SPP1hi Macrophages GrowthKey Summary Researchers at Hospital for.
Resistance Training Reduces Type 2 Diabetes Risk in AdultsKey Takeaways Consistent resistance training was.
Cardiac Aging Research Identifies PRDM16 Heart RegulatorKey Takeaways Researchers created a single-nucleus.
Digital Heart Twins Show Promise for AF Ablation PrecisionKey Summary Researchers developed patient-specific digital.
Alzheimer’s Disease Study Questions Glucosamine SafetyKey Summary New research published in.
WHO: Andes Hantavirus Not a COVID-19-Level ThreatKey Summary Andes hantavirus has drawn.
Genetic Screening Project Launches for Brazilian ParentsKey Summary Brazil is launching the.
CAR T-Cell Therapy Offers Hope for Highly Sensitized PatientsKey Summary Researchers at the University.
Gut Keystone Bacteria: How Diet Shapes Microbiome HealthKey Takeaways Researchers are identifying “gut.
Chronic Liver Disease in Europe Raises Public Health AlarmKey Summary A new report in.

Leave a Comment